Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gordan M Vujanić"'
Autor:
Ellen D’Hooghe, Rhoikos Furtwängler, Tanzina Chowdhury, Christian Vokuhl, Reem Al‐Saadi, Kathy Pritchard‐Jones, Norbert Graf, Gordan M. Vujanić
Publikováno v:
Cancer. 129:1930-1938
Autor:
Gordan M. Vujanić, Norbert Graf, Ellen D'Hooghe, Tanzina Chowdhury, Christian Vokuhl, Reem Al‐Saadi, Kathy Pritchard‐Jones, Patrick Melchior, Rhoikos Furtwängler
Publikováno v:
International Journal of Cancer. 152:1640-1647
Stage III Wilms' tumour (WT) represents a heterogeneous group which includes different criteria, but all stage III patients are treated according to the same study regiment. The aim of the study was to retrospectively analyse outcomes in patients wit
Autor:
William Mifsud, Rhoikos Furtwängler, Christian Vokuhl, Ellen D'Hooghe, Kathy Pritchard-Jones, Norbert Graf, Gordan M. Vujanić
Publikováno v:
European Journal of Cancer. 166:1-7
Anaplasia is an unfavourable prognostic histological feature in Wilms tumour (WT). Patients with stage I anaplastic WT (AWT) typically achieve good outcomes, albeit with more treatment than for stage I non-AWT. Since the SIOP-WT-2001 study, patients
Autor:
Gordan M, Vujanić, William, Mifsud, Tanzina, Chowdhury, Reem, Al-Saadi, Kathy, Pritchard-Jones
Publikováno v:
Cancer. 128:1666-1675
Since the International Society of Paediatric Oncology Wilms' Tumour 2001 (SIOP-WT-2001) study, focal anaplastic Wilms tumors (FAWTs) have been treated as intermediate-risk Wilms tumors (WTs), and diffuse anaplastic Wilms tumors (DAWTs) have been tre
Autor:
Abdelhafeez H. Abdelhafeez, Tea Reljic, Ambuj Kumar, Tahmina Banu, Sharon Cox, Andrew M. Davidoff, Ahmed Elgendy, Khalil Ghandour, J. Ted Gerstle, Jonathan Karpelowsky, Sue C. Kaste, Nahla Kechiche, Natia Esiashvili, Abdulrasheed Nasir, Amon Ngongola, Jin Marollano, Amabelle A. Moreno, Arlene Muzira, Jeannette Parkes, Lily J. Saldaña, Jaime Shalkow, Gordan M. Vujanić, Thelma Velasquez, Kokila Lakhoo, Sheena Mukkada, Simone Abib
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(12)
Survival of Wilms tumor (WT) is >90% in high-resource settings but
Autor:
Gordan M Vujanić, Lauren N Parsons, Ellen D'Hooghe, Amy L Treece, Paola Collini, Elizabeth J Perlman
Publikováno v:
HistopathologyReferences. 80(7)
Excellent outcomes for patients with Wilms' tumour (WT),90% for all stages together, have been achieved through researching WT in multicentre and multinational trials and studies in the last 50 years, led by two major groups-the International Society
Autor:
Gordan M, Vujanić, Ellen, D'Hooghe, Norbert, Graf, Christian, Vokuhl, Reem, Al-Saadi, Tanzina, Chowdhury, Kathy, Pritchard-Jones, Rhoikos, Furtwängler
Publikováno v:
International journal of cancerREFERENCES. 149(6)
In the SIOP Wilms' tumor (WT) studies, preoperative chemotherapy is used as primary treatment, and tumors are classified thereafter by pathologists. Completely necrotic WTs (CN-WTs) are classified as low-risk tumors. The aim of the study was to evalu
Publikováno v:
HistopathologyReferences. 79(5)
Datasets for histopathological reporting of many cancer types are developed by the International Collaboration on Cancer Reporting (ICCR), and are used in order to ensure standardised and uniformly accepted reporting as one of the essential requireme
Autor:
Thomas J, Jackson, Richard D, Williams, Jesper, Brok, Tanzina, Chowdhury, Milind, Ronghe, Mark, Powis, Kathy, Pritchard-Jones, Gordan M, Vujanić
INTRODUCTION: The International Society of Paediatric Oncology (SIOP) protocols recommend pre-operative chemotherapy appropriate for Wilms tumours (WT) in children with renal tumours aged ≥6 months, reserving biopsy for ‘atypical’ cases. The Ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d8f335d6f49b9da7628177101f199bdf
https://europepmc.org/articles/PMC6522371/
https://europepmc.org/articles/PMC6522371/
Autor:
Gordan M. Vujanić
Publikováno v:
Diagnostic Histopathology. 18:217-220